SEARCH RESULT

Total Matching Records found : 1104

Strong medicine for poor countries-Nayanima Basu

-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...

More »

Climate change meeting begins in Bonn -Indrajit Bose

-Down to Earth New deal must not attempt to rewrite or reinterpret the Convention, say developing countries The second session of the ADP, acronym for Ad hoc Working Group on Durban Platform, began in Bonn on April 29, 2013. At the opening session, countries outlined their positions on what they expect of the global deal on climate change, to be decided in 2015 and which will be implemented from 2020. The ADP, which...

More »

UN launches initiative to achieve ‘zero hunger’ in Asia and the Pacific

-The United Nations The United Nations today launched the Zero Hunger Challenge in Asia and the Pacific, calling on governments, farmers, scientists, business, civil society and consumers to work together to end hunger in the region where the majority of the world's undernourished people live. "Sustainable development and inclusive growth will not happen on empty stomachs," said Noeleen Heyzer, Executive Secretary of the UN Economic and Social Commission for Asia and the...

More »

In the ‘pharmacy of the world’ -PT Jyothi Datta

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

More »

In story of Saradha's crores, Bengal's forgotten hundreds -Madhuparna Das

-The Indian Express West Bengal is not new to chit fund scams. What is unique to the Saradha Group scandal is how it targeted the poorest and the most marginalised, leaving them on the verge of devastation. From 17-year-old agents who raised money from depositors to 50-year-old widows who invested money, the Saradha Group didn't discriminate in roping them in. Since the house of cards started collapsing, two agents and two...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close